Biggest News Aggregation in the World
📰 Pharma Services News

Page 42 - Pharma Services News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.

02.25.21 -- Developing Future Delivery Models For ATMPs

02.25.21 -- Developing Future Delivery Models For ATMPs     Seeq is hosting a live virtual event featuring pharmaceuticals and life sciences experts from Eli Lilly, Lonza, Amgen, and more on March 10, 2021. Mark your calendars and register to hear how other companies in your industry are using advanced analytics technology to turn their data into insights, drive process improvement, and increase profitability.   This is a live event, and the presentations wi...
Paola Lazzeri Anna Campanella Samsung Biologics Giulia Artalli Robin Bogner Frank Panofen

Recap: NeoGenomics Q4 Earnings

Recent Stock Performance Companys 52-week low was at $20.47 Price action over last quarter: Up 32.97% Company Description NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemist...
United States Clinical Services Neogenomics Inc Pharma Services Company Description Genomics Inc

NeoGenomics, Inc.: NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

NeoGenomics, Inc.: NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter Consolidated revenue increased 18% to $126 million Clinical Services revenue increased 14% to $107 million Pharma Services revenue increased 43% to $19 million Pharma Services backlog increased 60% to $209 million FT. MYERS, FL / ACCESSWIRE / February 24, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced fourth-quarter and full-year...
Fort Myers United States San Diego Aliso Viejo Douglasm Vanoort Charlie Eidson

02.16.21 -- Do These Recent Warning Letters Signal A Shift In FDA Enforcement?

02.16.21 -- Do These Recent Warning Letters Signal A Shift In FDA Enforcement?   Upload an image of your current/old CO2 incubator for a chance to win a brand new FREE NuAire In-Vitrocell NU-5810 CO2 Incubator. Other prizes include a monthly drawing for a branded Under Armour backpack, Camelbak metal water bottle, and various gift cards. All entries will receive a FREE NU-1582 CO2 Incubator Castered Platform with your next NuAire CO2 Incubator purchase. Contes...
Dominic Hyde Stephen Natoli Mark Robbins Oliver Stauffer Matthew Gorton Hemi Sagi

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Clinical Trial Supplies Market Study including Growth Factors, New Top Players, Competitive Analysis by regions from 2021 to 2027 – KSU

Data Bridge Market Research recently added “ Clinical Trial Supplies Market  by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries. Clinical Trial Su...
Hong Kong United Kingdom Parexel International Corporation Almac Group Valium Medical Market Research

Global Proteomics Partnering Terms and Agreements Analysis Report 2020

Global Proteomics Partnering Terms and Agreements Analysis Report 2020 News provided by Share this article Share this article ResearchAndMarkets.coms offering. The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter Proteomics partnering deals. The...
United Kingdom Ch Ungch Ong Bukto South Korea Kyongsang Bukto United States Mecklenburg Vorpommern

Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

Jan 21 2021 Read 877 Times Thermo Fisher Scientific Inc and Groupe Novasep SAS have announced that Thermo Fisher has completed the acquisition of Henogen SA, Novasep’s viral vector manufacturing business in Belgium for approximately €725 million in cash. Novasep’s viral vector manufacturing business provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers. With two locations in Seneffe and Gosselies, Belgium, Novasep’s ...
Waals Gewest United States Michel Lagarde Michel Spagnol Thermo Fisher Scientific Inc Pharma Services

01.21.21 -- Using Production And Postmarket Data To Validate FMEA Assumptions

01.21.21 -- Using Production And Postmarket Data To Validate FMEA Assumptions   Acepodias Dr. Sony Hsiao, CEO, and Dr. Mark Gilbert, SVP of R&D, join Business of Biotech for a discussion on the companys approach to dramatically reducing the cost of cell therapy development, manufacturing, and administration via its oNK, CAR, and ACC candidates. Listen now and subscribe so you never miss an episode. Featured Editorial By Mark Durivage, Quality Systems Complian...
Paul Magreta Sheri Gimigliano Beth Kendserky Dan Updyke Spencer Bolte James Faust

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science